FDA/CDC

Opioid deaths in the ED increase nationally


 

FROM MMWR

The greatest increase was seen in the Midwest region (69.7%), followed by the West (40.3%), Northeast (21.3%), Southwest (20.2%), and Southeast (14%).

Death rates rose across all demographics, regardless of sex or age.

While Delaware recorded some of the highest increases in deaths, Massachusetts, New Hampshire, and Rhode Island decreased, although not within statistical significance.

“These decreases may possibly be related to implementation of interventions, including expansion of access to medication-assisted treatment,” said Dr. Schuchat. “The decrease in Kentucky during this period of time may reflect some fluctuations in drug supply.”​

Recommended Reading

In close vote, advisory panel prefers Shingrix over Zostavax
MDedge Neurology
Eliminating patient-controlled analgesia accelerates discharge after bariatric surgery
MDedge Neurology
Conference News Roundup—American Society of Anesthesiologists
MDedge Neurology
Fremanezumab may reduce chronic migraine frequency
MDedge Neurology
New buprenorphine formulation approved for medication-assisted treatment
MDedge Neurology
Novel herpes zoster vaccine is more cost effective than old vaccine
MDedge Neurology
Persistent opioid use a risk after surgery in teens and young adults
MDedge Neurology
Serotonin syndrome warnings magnify its rare probability
MDedge Neurology
Serotonin syndrome risk with triptans and antidepressants ‘very low’
MDedge Neurology
FDA alerts doctors to stop administering compounded products
MDedge Neurology